ULTRASIS - ONWARDS AND UPWARDS

bots, the trouble is that the Final Appraisal Determination (FAD) covers a range of ccbt products for different mental health problems. So, while BtB has NICE approval for treatment of mild depression, the appeal by STSolutions over their product (which is for OCD) has caused a delay on the whole FAD - very frustrating, but we'll get there.

And no, it's not the "pill makers chucking a spanner in the work", they were not part of the NICE consultation process and therefore not able to appeal against any NICE decision. The government is well behind CCBT, see the link in my prev post to the Lord Layard speech.